SNOA
Sonoma Pharmaceuticals, Inc.
NASDAQ · Healthcare · Drug Manufacturers - Specialty & Generic · US
$1.33
+0.38%Margins
Gross margin
38.9%
EBITDA margin
-7.3%
EBIT margin
-6.4%
Net margin
-10.3%
FCF margin
-9.8%
-34.3%
Return on equity
-12.5%
Return on assets
-19.2%
Return on invested capital
1.37x
Asset turnover
-$2.0M
Cash from operations
$1.11
Cash per share
Margins, returns on capital and operating efficiency from the latest trailing period · Data as of Jun 1, 2026